GUTS PE Ratio & Valuation, Is GUTS Overvalued

Historical Valuation

Fractyl Health Inc (GUTS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.93. The fair price of Fractyl Health Inc (GUTS) is between NaN to NaN according to relative valuation method.

Relative Value

Fair Zone

NaN-NaN

Current Price：0.49

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Fractyl Health Inc (GUTS) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Fractyl Health Inc (GUTS) has a current Price-to-Book (P/B) ratio of -93.61. Compared to its 3-year average P/B ratio of -7.25, the current P/B ratio is approximately 1191.09% higher. Relative to its 5-year average P/B ratio of -7.25, the current P/B ratio is about 1191.09% higher. Fractyl Health Inc (GUTS) has a Forward Free Cash Flow (FCF) yield of approximately -28.15%. Compared to its 3-year average FCF yield of -56.05%, the current FCF yield is approximately -49.77% lower. Relative to its 5-year average FCF yield of -56.05%, the current FCF yield is about -49.77% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for GUTS competitors is 269.68, providing a benchmark for relative valuation. Fractyl Health Inc Corp (GUTS.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of GUTS increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of GUTS in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is GUTS currently overvalued or undervalued?

What is Fractyl Health Inc (GUTS) fair value?

GUTS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Fractyl Health Inc (GUTS) is between NaN to NaN according to relative valuation method.

How does GUTS's valuation metrics compare to the industry average?

The average P/S ratio for GUTS's competitors is 269.68, providing a benchmark for relative valuation. Fractyl Health Inc Corp (GUTS) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.

What is the current P/B ratio for Fractyl Health Inc (GUTS) as of Mar 11 2026?

As of Mar 11 2026, Fractyl Health Inc (GUTS) has a P/B ratio of -93.61. This indicates that the market values GUTS at -93.61 times its book value.

What is the current FCF Yield for Fractyl Health Inc (GUTS) as of Mar 11 2026?

As of Mar 11 2026, Fractyl Health Inc (GUTS) has a FCF Yield of -28.15%. This means that for every dollar of Fractyl Health Inc's market capitalization, the company generates -28.15 cents in free cash flow.

What is the current Forward P/E ratio for Fractyl Health Inc (GUTS) as of Mar 11 2026?

As of Mar 11 2026, Fractyl Health Inc (GUTS) has a Forward P/E ratio of -3.31. This means the market is willing to pay $-3.31 for every dollar of Fractyl Health Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Fractyl Health Inc (GUTS) as of Mar 11 2026?

As of Mar 11 2026, Fractyl Health Inc (GUTS) has a Forward P/S ratio of 0.00. This means the market is valuing GUTS at $0.00 for every dollar of expected revenue over the next 12 months.

GUTS Valuation